OnDemand: Implementation of Collaborative Drug Therapy Management....

Cost $99
Duration: One Hour

Implementation of Collaborative Drug Therapy Management Services in a Large Public Health Care System in the United States

This session will review the implementation and outcomes of a Collaborative Drug Therapy Management (CDTM) program at a large public health care system in the United States. Clinical pharmacists are uniquely trained to address key issues surrounding management of diabetes, including the pharmacotherapy management, diabetes self-management education and medication adherence. CDTM allows pharmacists to co-manage patients under a collaborative practice agreement with a patient’s primary care physician. 

Target Audience

•    Community-based organizations
•    Health plans
•    Health systems
•    Outpatient providers

Learning Objectives

•    Review select landmark trials leading to the generalized acceptance of pharmacist collaborative practice agreements
•    Understand the pharmacist’s educational/experiential training for providing CDTM services
•    Describe the framework needed to implement CDTM services in a health system

Course summary
Available credit: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 PCMH CCE
Course opens: 
Course expires: 

Joshua P. Rickard, PharmD, MPH, BCACP

Josh Rickard is currently a Senior Director in the Office of Ambulatory Care and Population Health at New York City Health + Hospitals. In this position, Dr. Rickard leads the effort to build and maintain Collaborative Drug Therapy Management Pharmacy within the health system.

Dr. Rickard obtained a doctorate of pharmacy degree from the University of South Carolina and his Master of Public Health from the London School of Hygiene and Tropical Medicine. He completed his residency training at the James J. Peters VA Medical Center in the Bronx, NY and Intermountain Healthcare in Salt Lake City, UT specializing in Ambulatory Care Clinical Pharmacy. Dr. Rickard currently a Board-Certified Pharmacotherapy Specialist and Ambulatory Care Pharmacist, as well as a Certified Tobacco Treatment Specialist and Diabetes Care and Education Specialist.



In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide Interprofessional Continuing Education for the healthcare team. 

This educational activity is approved for a maximum of 1.0 AMA PRA Category 1 Credit™. 

This educational activity is approved for 1.0 nursing contact hours.*

The assigned universal program number: JA0004597-0000-22-029-H04P. Upon successful completion of this program (attending the full session and completing a program evaluation), participants will access CPE Monitor on the ACPE website to locate and track their CPE statement of credit.

This live course grants 1.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts.  

* Please note – You must attend the entire program to be eligible for total number of contact hours.

Disclosure of Relevant Financial Relationships

The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations.

For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution.  For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant financial relationships exist with the following companies/organizations:

Joshua P. Rickard: None

Additional Planning Committee Members:
Tammy Donnelly: None 

 This program was developed in part by NCQA staff.

This program received no commercial support.

Available Credit

  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 PCMH CCE


Please login or register to take this course.